University of Utah Unveils AI Toolkit for Early Disease Prediction
Researchers at the University of Utah have introduced a new AI toolkit named RiskPath, designed to predict chronic diseases before symptoms appear, announced in a press release. Developed by the Department of Psychiatry and the Huntsman Mental Health Institute, RiskPath uses Explainable Artificial Intelligence (XAI) to analyze health data and identify at-risk individuals with an accuracy of 85-99%.
RiskPath represents a significant advancement in disease prediction by utilizing advanced timeseries AI algorithms. These algorithms provide insights into how risk factors interact and change over time, allowing for more targeted preventive strategies. The toolkit has been validated across three major long-term patient cohorts, successfully predicting conditions such as depression, anxiety, ADHD, hypertension, and metabolic syndrome.
The research team is exploring how RiskPath can be integrated into clinical decision support systems and preventive care programs. They aim to expand their research to include additional diseases and diverse populations, potentially transforming preventive healthcare delivery.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
FactorLab Adds AI Risk Tools to SmartTagIt
Verana Health Adds AI Tools and Ophthalmology Datasets
LUNGevity Awards $2 Million for Lung Nodule Risk Studies
NYU Langone Tests AI Tool to Fill Radiology Training Gaps
ARPA-H Funds $28.6 Million AI Protein Research Project
Daily AI Brief: the AI news that matters, in your inbox.